John Lunger
CIK 1784487 · Chief Patient Supply Officer · last filed 2025-02-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
29
Lifetime Open-Market Net
-$218.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Chief Patient Supply Officer | 7,510 | $0.06 | $435 | -$218.0K | 27 | 2025-02-20 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Director | — | $0.00 | — | $0 | 1 | 2022-03-07 |
| ASND | Chief Patient Supply Officer | — | $218.06 | — | $0 | 1 | 2019-08-05 |
Recent Filings · Page 2 of 3
29 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-04 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −1,100 | -$1.9K | EDGAR |
| 2022-08-01 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −2,983 | -$5.3K | EDGAR |
| 2022-07-05 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −1,973 | -$3.3K | EDGAR |
| 2022-03-07 | GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −4,368 | -$13.9K | EDGAR |
| 2022-01-13 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −4,846 | -$17.2K | EDGAR |
| 2022-01-13 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-05 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −1,070 | -$4.3K | EDGAR |
| 2021-08-02 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −2,939 | -$10.5K | EDGAR |
| 2021-07-02 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −1,907 | -$8.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.